PharmacyCodes



(+/-)-N-Methyl-2-phenylsuccinimide en es it fr

(+/-)-N-Methyl-2-phenylsuccinimide Brand names, (+/-)-N-Methyl-2-phenylsuccinimide Analogs

(+/-)-N-Methyl-2-phenylsuccinimide Brand Names Mixture

  • No information avaliable

(+/-)-N-Methyl-2-phenylsuccinimide Chemical_Formula

C11H11NO2

(+/-)-N-Methyl-2-phenylsuccinimide RX_link

No information avaliable

(+/-)-N-Methyl-2-phenylsuccinimide fda sheet

(+/-)-N-Methyl-2-phenylsuccinimide msds (material safety sheet)

(+/-)-N-Methyl-2-phenylsuccinimide Synthesis Reference

No information avaliable

(+/-)-N-Methyl-2-phenylsuccinimide Molecular Weight

189.211 g/mol

(+/-)-N-Methyl-2-phenylsuccinimide Melting Point

72 oC

(+/-)-N-Methyl-2-phenylsuccinimide H2O Solubility

7020 mg/L

(+/-)-N-Methyl-2-phenylsuccinimide State

Solid

(+/-)-N-Methyl-2-phenylsuccinimide LogP

1.079

(+/-)-N-Methyl-2-phenylsuccinimide Dosage Forms

Capsules

(+/-)-N-Methyl-2-phenylsuccinimide Indication

For the treatment of epilepsy

(+/-)-N-Methyl-2-phenylsuccinimide Pharmacology

Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.

(+/-)-N-Methyl-2-phenylsuccinimide Absorption

Rapid and complete

(+/-)-N-Methyl-2-phenylsuccinimide side effects and Toxicity

No information avaliable

(+/-)-N-Methyl-2-phenylsuccinimide Patient Information

No information avaliable

(+/-)-N-Methyl-2-phenylsuccinimide Organisms Affected

Humans and other mammals